Skip Navigation


Human Molecular Genetics Advance Access originally published online on August 29, 2006
Human Molecular Genetics 2006 15(18):2791-2803; doi:10.1093/hmg/ddl221
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow A corrigendum has been published
Right arrow All Versions of this Article:
15/18/2791    most recent
ddl221v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in Hum. Mol. Genet.
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (9)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Zhou, H.
Right arrow Articles by Treves, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhou, H.
Right arrow Articles by Treves, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Characterization of recessive RYR1 mutations in core myopathies

Haiyan Zhou1,{dagger}, Naohiro Yamaguchi2,{dagger}, Le Xu2, Ying Wang2, Caroline Sewry3, Heinz Jungbluth1,4, Francesco Zorzato5, Enrico Bertini6, Francesco Muntoni1, Gerhard Meissner2 and Susan Treves7,*

1 The Dubowitz Neuromuscular Centre, Imperial College, Hammersmith Hospital, London W120NN, UK, 2 Department of Biochemistry and Biophysics, University of North Carolina, Chapel Hill, NC 27599-7260, USA, 3 Centre for Inherited Neuromuscular Disorders, Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Trust, Oswestry SY10 7AG, UK, 4 Department of Paediatric Neurology, Evelina Children's Hospital, St Thomas' Hospital, London, UK, 5 Dipartimento di Medicina Sperimentale e Diagnostica, Universita'di Ferrara, 44100 Ferrara, Italy, 6 Unit of Molecular Medicine, Ospedale Bambin Gesu', Rome, Italy and 7 Departments of Anaesthesia and Research, Basel University Hospital, 4031 Basel, Switzerland

* To whom correspondence should be addressed at: Departments of Anesthesia and Research, Basel University Hospital, Hebelstrasse 20, 4031 Basel, Switzerland. Tel: +41 61 265 2373; Fax: +41 61 265 3702; Email: susan.treves{at}unibas.ch

Received July 14, 2006; Accepted August 3, 2006

We have characterized at the molecular level, three families with core myopathies carrying apparent recessive mutations in their RYR1 gene and studied the pharmacological properties of myotubes carrying endogenous mutations as well as the properties of mutant channels expressed in HEK293 cells. The proband of family 1 carried p.Ala1577Thr+p.Gly2060Cys in trans, having inherited a mutation from each parent. Immunoblot analysis of proteins from the patient's skeletal muscle revealed low levels of ryanodine receptor (RyR1) but neither substitution alone or in combination affected the functional properties of RyR1 channels in a discernable way. Two affected siblings in family 2 carried p.Arg109Trp+p.Met485Val substitutions in cis, inherited from the unaffected father. Interestingly, both affected siblings only transcribed the mutated paternal allele in skeletal muscle, whereas the maternal allele was silent. Single-channel measurements showed that recombinant, mutant RyR1 channels carrying both substitutions lost the ability to conduct Ca2+. In this case as well, low levels of RyR1 were present in skeletal muscle extracts. The proband of family 3 carried p.Ser71Tyr+p.Asn2283His substitutions in trans. Recombinant channels with Asn2283His substitution showed an increased activity, whereas recombinant channels with p.Ser71Tyr+p.Asn2283His substitution lost activity upon isolation. Taken together, our data suggest major differences in the ways RYR1 mutations may affect patients with core myopathies, by compromising RyR1 protein expression, stability and/or activity.


{dagger} The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in Hum. Mol. Genet.:

Characterization of recessive RYR1 mutations in core myopathies
Haiyan Zhou, Naohiro Yamaguchi, Le Xu, Ying Wang, Caroline Sewry, Heinz Jungbluth, Francesco Zorzato, Enrico Bertini, Francesco Muntoni, Gerhard Meissner, and Susan Treves
Hum. Mol. Genet. 2007 10.1093/hmg/ddm092. [PDF]  



This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
L. Xu, Y. Wang, N. Yamaguchi, D. A. Pasek, and G. Meissner
Single Channel Properties of Heterotetrameric Mutant RyR1 Ion Channels Linked to Core Myopathies
J. Biol. Chem., March 7, 2008; 283(10): 6321 - 6329.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Zvaritch, F. Depreux, N. Kraeva, R. E. Loy, S. A. Goonasekera, S. Boncompagni, A. Kraev, A. O. Gramolini, R. T. Dirksen, C. Franzini-Armstrong, et al.
An Ryr1I4895T mutation abolishes Ca2+ release channel function and delays development in homozygous offspring of a mutant mouse line
PNAS, November 20, 2007; 104(47): 18537 - 18542.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
H. Zhou, H. Jungbluth, C. A. Sewry, L. Feng, E. Bertini, K. Bushby, V. Straub, H. Roper, M. R. Rose, M. Brockington, et al.
Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies
Brain, August 1, 2007; 130(8): 2024 - 2036.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.